Navigation Links
EvoNexus company PhageTech closes $2.4 million Series A financing for commercialization of one- minute blood and urine test.
Date:10/1/2015

IRVINE, Calif., Oct. 1, 2015 /PRNewswire-USNewswire/ -- EvoNexus Irvine company PhageTech, Inc. announced that it has raised $2.4 million in Series A funding from a group of early stage investors co-led by Mark IV Capital and Black River Investments. The funding will be used to complete development and FDA clearance of its revolutionary PhageTech BioSensor™ technology.

EvoNexus is the leading startup technology incubator in Southern California with locations in San Diego and Irvine. It has the largest network of entrepreneurs, mentors, tech industry leaders, and investors in the region.

"EvoNexus is always looking for startups developing technological breakthroughs, and PhageTech's biosensor technology certainly qualifies," says EvoNexus CEO Rory Moore. "By being able to accurately detect certain types of early stage cancers and other diseases PhageTech technology will enable potential treatments that may produce better outcomes for the patient through early detection and lower healthcare costs for treatments required in later stage cancer patients." PhageTech is a great example of the partnership being formed with the University of California, Irvine, and EvoNexus.

The closest thing to a cure for cancer is early detection. PhageTech Biosensors will enable early detection of cancers and other diseases while making disease detection instantaneous, simpler, affordable, near patient and readily accessible world-wide.

CEO Richard Henson states, "Our technology enables an entire new category of near patient testing with tremendous benefits in portability, simplicity, time to result and cost over the current standard in lab- based diagnostics (e.g. sending samples out to a lab and waiting for results). The entire diagnostic test is contained in a chip the size of a postage stamp without compromising accuracy, enabling physicians to make instant treatment decisions.

"Our vision is to develop PhageTech Biosensors and readers for physicians as well as patients (e.g. through an app on a cell phone). It will especially have enormous implications for developing countries with minimal resources who are in need of simple, low cost, near patient testing. Our goal in 10 years is to touch over one billion people."

Developed with NIH funds at the University of California, Irvine, the PhageTech Biosensors will be interfaced with portable readers enabling inexpensive, quantitative, near patient testing in under one minute providing physicians with real-time valuable information for quicker diagnoses, treatment and improved patient outcomes.

About PhageTech:
PhageTech, Inc. is developing a transformative medical diagnostics platform that will enable immediate, near patient, and affordable disease testing worldwide, improving health, lowering costs and saving patient lives. Our vision is that in 10 years, we will have positively touched the lives of over a billion people.

For more information, visit http://www.phagetech.com/.

About EvoNexus:
EvoNexus is a technology incubator for Southern California's startup and entrepreneurial community with locations in San Diego and Irvine. EvoNexus empowers motivated entrepreneurs to turn their transformative ideas into fundable, commercially viable companies, and leverages community resources to provide what entrepreneurs need to be successful. EvoNexus has three locations across Southern California thanks to the Irvine Company's dedication to entrepreneurship and the innovation economy.

For more information, visit http://www.evonexus.org.

Media Contacts:
Arlene Bumb
asbumb@phagetech.com
Vice President Marketing and Business Development

Carolyn Liikala
858-886-6277
cliikala@evonexus.org
Program Manager, Irvine

Chris Norris
720-648-1473
cnorris@evonexus.org
Communications & Marketing Manager, San Diego & Irvine

 

 


'/>"/>
SOURCE EvoNexus
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Regen BioPharma, Inc. Director of Molecular Therapeutics to Speak at Stem Cell Conference Regarding Leukemia Research Being Conducted by the Company
2. Entest BioMedical Updates Company Status and Future Plans
3. Russian Company Semiotik Comes Into Indian Market of Microchips for Assay of Blood and Donor Plasma
4. Perrigo Company To Present At The Morgan Stanley 2015 Global Healthcare Conference
5. Mindray Announces Receipt of Revised Non-binding Proposal to Acquire the Company at US$27 per ADS or US$27 per Ordinary Share
6. Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering
7. VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa
8. Elekta to Host Cancer Survivorship Event at Companys Learning and Innovation Center (LINC) in Atlanta
9. AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company
10. Patterson Medical Positioned for Continued Growth as a Newly Independent Company
11. IP Shakti, LLC Changes Company Name to Prediqtus, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... of Charleston. Dr. Robert Carimi and his caring team are thrilled to create ... from dental anxiety in Charleston, SC. The mission of Sedation Dentistry ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... at Western Pennsylvania & Ohio Valley Oral & Maxillofacial Surgery. This cutting-edge practice ... All-on-4® full arch dental implants to predictable jaw surgery with 3D ...
(Date:10/8/2019)... ... October 08, 2019 , ... Villa Healthcare, a leader in skilled ... chose to work at Villa and what their work means to them. The ... CFO Steve Nagel prepared the giant checks. Anticipation was high as finalists gathered ...
Breaking Medicine Technology:
(Date:10/8/2019)... , ... October 08, 2019 , ... ... appointed distinguished innovator, Dr. Jerry Henderson as Chief Medical Officer. Dr. Henderson will ... analytics platforms. , Dr. Henderson previously served as Chair of both the ...
(Date:10/8/2019)... ... October 08, 2019 , ... At the ... 4medica® President Gregg Church will inform conference attendees how the 4medica ... management-by starting with the right, clean patient data. The single platform interfaces to ...
(Date:10/8/2019)... IRVINE, Calif. (PRWEB) , ... October 08, 2019 , ... ... by workplace culture and compensation monitoring site, Comparably. Smile Brands, a leading dental support ... founded in the company’s mission to deliver Smiles for Everyone®. The Happiness Award is ...
(Date:10/8/2019)... ... October 08, 2019 , ... EBSCO Information ... integrate skills and procedures content from Dynamic Health™ into the MCN ... health professionals master critical skills. MCN provides custom policy content, document management software ...
(Date:10/8/2019)... ... , ... On November 9, 2019, husband and wife dental team, Dr.’s Michael and Azita Mansouri, ... marks the ninth consecutive year that Mansouri Family Dental Care & Associates has ... event has always had a great turnout, serving over 300 people in a single day ...
Breaking Medicine News(10 mins):